R. Andrew Harkins

527 total citations
7 papers, 69 citations indexed

About

R. Andrew Harkins is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, R. Andrew Harkins has authored 7 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 2 papers in Genetics. Recurrent topics in R. Andrew Harkins's work include Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (3 papers) and Cancer Genomics and Diagnostics (2 papers). R. Andrew Harkins is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (3 papers) and Cancer Genomics and Diagnostics (2 papers). R. Andrew Harkins collaborates with scholars based in United States and Czechia. R. Andrew Harkins's co-authors include Christopher R. Flowers, Jean L. Koff, Jordan Goldstein, Andrés Chang, Sandeep S. Davé, Jeffrey M. Switchenko, Ankur Singh, Michelle Lee, Michael C. Churnetski and Deniz Peker and has published in prestigious journals such as Blood, Cancer and The Cancer Journal.

In The Last Decade

R. Andrew Harkins

6 papers receiving 69 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Andrew Harkins United States	4	45	27	20	13	11	7	69
Astrid Pavlovsky Argentina	5	32 0.7×	22 0.8×	11 0.6×	18 1.4×	4 0.4×	21	62
G.K. Bascom United States	2	41 0.9×	27 1.0×	16 0.8×	8 0.6×	8 0.7×	2	63
Will Donnellan United States	4	46 1.0×	37 1.4×	14 0.7×	16 1.2×	3 0.3×	6	73
Alfonso Martín Carnicero Spain	4	37 0.8×	10 0.4×	41 2.0×	9 0.7×	8 0.7×	10	69
Jad Bsat United States	3	64 1.4×	33 1.2×	45 2.3×	3 0.2×	17 1.5×	3	68
Krista M. Isaac United States	6	60 1.3×	32 1.2×	61 3.0×	22 1.7×	8 0.7×	11	105
Saurabh Rajguru United States	5	32 0.7×	49 1.8×	19 0.9×	20 1.5×	12 1.1×	9	84
Noel Laudi United States	4	36 0.8×	43 1.6×	14 0.7×	7 0.5×	10 0.9×	6	56
Abderrazak El Yamani France	4	43 1.0×	36 1.3×	28 1.4×	15 1.2×	6 0.5×	6	55
Harry J. Han United States	5	16 0.4×	34 1.3×	18 0.9×	45 3.5×	43 3.9×	13	102

Countries citing papers authored by R. Andrew Harkins

Since Specialization

Citations

This map shows the geographic impact of R. Andrew Harkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Andrew Harkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Andrew Harkins more than expected).

Fields of papers citing papers by R. Andrew Harkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Andrew Harkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Andrew Harkins. The network helps show where R. Andrew Harkins may publish in the future.

Co-authorship network of co-authors of R. Andrew Harkins

This figure shows the co-authorship network connecting the top 25 collaborators of R. Andrew Harkins. A scholar is included among the top collaborators of R. Andrew Harkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Andrew Harkins. R. Andrew Harkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lee, Michelle, R. Andrew Harkins, Michael C. Churnetski, et al.. (2023). Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder. Current Oncology Reports. 25(8). 883–895. 2 indexed citations

2.

Koff, Jean L., et al.. (2020). Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma. Cancer. 126(15). 3493–3503. 16 indexed citations

3.

Harkins, R. Andrew, et al.. (2019). Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 20(4). 234–243.e10.

4.

Harkins, R. Andrew, et al.. (2019). Cost burden of diffuse large B-cell lymphoma. Expert Review of Pharmacoeconomics & Outcomes Research. 19(6). 645–661. 15 indexed citations

5.

Harkins, R. Andrew, et al.. (2019). Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma. Expert Review of Hematology. 12(11). 959–973. 26 indexed citations

6.

Harkins, R. Andrew, et al.. (2019). Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic Leukemia. The Cancer Journal. 25(6). 418–427. 9 indexed citations

7.

Harkins, R. Andrew, et al.. (2019). A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma. Blood. 134(Supplement_1). 3416–3416. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact